CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1

Current Eye Research

Volumn 34, Issue 3, 2009, Pages 241-249

  Gordon, Y Jerold ^a,c   Romanowski, Eric G ^a   Shanks, Robert M Q ^a   Yates, Kathleen A ^a   Hinsley, Heather ^b   Pereira, H Anne ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c University of Pittsburgh School of Medicine   (United States)

Author keywords

Adenovirus; Antimicrobial peptide; Azurocidin; CAP37; Herpes simplex virus

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CAP37 PEPTIDE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISULFIDE BOND; DOSE RESPONSE; DRUG MECHANISM; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SEROTYPE; VIRUS INHIBITION;

ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIVIRAL AGENTS; BLOOD PROTEINS; CAPSID; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 1, HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 62249188017     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802714066     Document Type: Article

References (35)

1. Pereira HA. Novel therapies based on cationic antimicrobial peptides Curr Pharm Biotechnol. 2006;7:229-234.
2. Linzmeier RM, Ganz T. Copy number polymorphisms are not a common feature of innate immune genes. Genomics. 2006;88:122-126.
3. Nilsson M, Sørensen OE, Mörgelin M, Weineisen M, Sjöbring U, Herwald H. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators. Thromb Haemost. 2006;95:982-990.
4. Flodgaard H, Ostergaard E, Bayne S, et al. Covalent structure of two novel neutrophil leucocyte-derived proteins of porcine and human origin. Neutrophil elastase homologueswith strong monocyte and fibroblast chemotactic activities. Eur J Biochem. 1991;197:535-547.
5. Ruan X, Chodosh J, Callegan MC, et al. Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2002;43:1414-1421.
6. Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun. 1984;45:29-35.
7. Campanelli D, Detmers PA, Nathan CF, Gabay JE. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J Clin Invest. 1990;85:904-915.
8. Pereira, HA, Erdem I, Pohl J, Spitznagel JK. Synthetic bactericidal peptide based on CAP37: A 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci USA. 1993;90:4733-4737.
9. Almeida RP, Vanet A, Witko-Sarsat V, et al. Azurocidin, a natural antibiotic from human neutrophils: Expression, antimicrobial activity, and secretion. Protein Expr Purif. 1996;7:355-366.
10. McCabe D, Cukierman T, Gabay JE. Basic residues in azurocidin/HBP contribute to both heparin binding and antimicrobial activity. J Biol Chem. 2002;277:27477-27488.
11. Luritzen B, Lykkesfeldt J, Djurup R, Flodgaard H, Svendsen O. Effects of heparin-binding protein (CAP37/azurocidin) in a porcinemodel of Actinobacillus pleuropneumoniae-induced pneumonia. Pharmacol Res. 2005;51:509-514.
12. Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 1990;85:1468-1476.
13. Okuyama Y, Cho JH, Nakajima Y, et al. Binding between azurocidin and calreticulin: Its involvement in the activation of peripheral monocytes. J Biochem (Tokyo). 2004;135:171-177.
14. Brackett DJ, Lerner, MR, Lacquement MA, He R, Pereira HA. A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infect Immun. 1997:65:2803-2811.
15. Lee TD, Gonzalez ML, Kumar P, Grammas P, Pereira HA. CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers. Microvasc Res. 2003;66:38-48.
16. Gonzalez ML, Ruan X, Kumar P, Grammas P, Pereira HA. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res. 2004;67:168-181.
17. Pereira HA, Ruan X, Gonzalez ML, Tsyshevskaya-Hoover I, Chodosh J. Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2004;45:4284-4292.
18. Gordon YJ, Huang LC, Romanowski EG, et al. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res. 2005;30:385-394.
19. McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci. 2005;46:1379-1385.
20. Ikeda A, Sakimoto T, Shoji M, Sawa J. Expression of alpha- and beta-defensins in human ocular surface tissue. Jpn J Ophthalmol. 2005;49:73-78.
21. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocular Surf. 2004;2:229-247.
22. Harvey SA, Romanowski EG, Yates KA, Gordon YJ. Adenovirus-directed ocular innate immunity: The role of conjunctival defensin-like chemokines (IP-10, I-TAC) and phagocytic human defensin-alpha. Invest Ophthalmol Vis Sci. 2005;46:3657-3665.
23. Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antiviral Res. 2004;64:119-126.
24. Sinha S, Cheshenko N, Lehrer RI, Herold BC. NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother. 2003;47:494-500.
25. dO-phosphohydroxylysine-containing peptide. Anal Biochem. 2002;306:124-134.
26. Rexroad J, Wiethoff CM, Green AP, Kierstead TD, Scott MO, Middaugh CR. Structural stability of adenovirus type 5. J Pharm Sci. 2003;92:665-667.
27. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol. 2005;79:1992-2000.
28. Pham CTN. Neutrophil serine proteases: Specific regulators of inflammation. Nature Rev/Immunol. 2006;6:541-550.
29. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389-395.
30. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers. 2002;66:236-248.
31. Bultmann HC, Brandt CR. Peptides containing membrane-transiting motifs inhibit virus entry. J Biol Chem. 2002;277:36018-36023.
32. Quinones-Mateu ME, Lederman MM, Feng Z, et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS. 2003;17:F39-48.
33. Spitznagel JK. Antibiotic proteins of human neutrophils. J Clin Invest. 1990;86:1381-1386.
34. Ostergaard E, Flodgaard H. A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion. J Leukoc Biol. 1992;51:316-323.
35. Haynes RJ, McElveen JE, Dua HS, Tighe PJ, Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 2000;41:3026-3031.